{
  "id": 3564661,
  "title": "FDA approves groundbreaking new pancreatic cancer drug",
  "url": "https://urgent.news/2026/08/26/fda-approves-groundbreaking-new-pancreatic-cancer-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-26T17:50:34.000Z",
  "source": {
    "name": "The Hill",
    "slug": "the-hill",
    "url": "https://thehill.com/policy/healthcare/6052834-fda-approves-pancreatic-cancer-drug/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms of cancer. The once-daily pill, called daraxonrasib and manufactured by Revolution Medicines, will be sold under the brand name Rasonque. It was approved for patients who already tried...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}